Cannabinoids and the Brain /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer US : Imprint: Springer,
2008.
|
| Edición: | 1st ed. 2008. |
| Materias: |
Tabla de Contenidos:
- Molecular Biology, Pharmacology, Anatomy, and Physiology of the Endocannabinoid and Related Lipidergic Signaling Systems in the Brain
- An Historical Introduction to the Endocannabinoid and Endovanilloid Systems
- Biosynthesis of Anandamide and 2-Arachidonoylglycerol
- Removal of Endocannabinoids by the Body: Mechanisms and Therapeutic Possibilities
- Other Cannabimimetic Lipid Signaling Molecules
- CB1 Cannabinoid Receptors: Molecular Biology, Second Messenger Coupling and Polarized Trafficking in Neurons
- CB2 Cannabinoid Receptors: Molecular, Signaling, and Trafficking Properties
- CB1 and CB2 Receptor Pharmacology
- Functional Molecular Biology of the TRPV1 Ion Channel
- Alternative Interacting Sites and Novel Receptors for Cannabinoid Ligands
- Anatomical Distribution of Receptors, Ligands and Enzymes in the Brain and in the Spinal Cord: Circuitries and Neurochemistry
- Endocannabinoids at the Synapse: Retrograde Signaling and Presynaptic Plasticity in the Brain
- Endocannabinoid Functions in Neurogenesis, Neuronal Migration, and Specification
- The Endocannabinoid System in Clinical Neuroscience and Experimental Neuropsychiatry
- Cannabinoids in the Management of Nausea and Vomiting
- Endocannabinoids in Energy Homeostasis and Metabolic Disorders
- Cannabinoids and Neuroprotection
- Neuroinflammation and the Glial Endocannabinoid System
- Targeting Cannabinoid Receptors in Brain Tumors
- Cannabinoids for the Control of multiple Sclerosis
- Endocannabinoids in Alzheimer's Disease
- The Endocannabinoid System as a Therapeutic Target in Epilepsy
- The Endocannabinoid System in the Physiology and Pathology of the Basal Ganglia
- The Endocannabinoid System is a Major Player in Schizophrenia
- The Cannabinoid Controversy: Cannabinoid Agonists and Antagonists as Potential Novel Therapies for Mood Disorders
- Role of Cannabinoid Receptors in Anxiety Disorders.